JAK2 and breast cancer: They can inhibit JAK2 and STAT3–related protein and mRNA expression; regulate upstream and downstream pathway indicators; inhibit tumor growth, proliferation, and migration; promote tumor cell apoptosis; and reduce the inflammatory response, thereby exerting anti-BC effects (Figure 6).